Roundtable New Horizons in AF: Personalised
Published: 09 September 2020
-
Views:
44
-
Likes:
7
-
Views:
44
-
Likes:
7
Overview
Effectively differentiating between potentially life-threatening causes of syncope and more benign causes requires careful evaluation. Tilt-testing is used variably across cardiovascular units around the world. Its sensitivity and specificity in identifying causes for syncope is debated, yet it can provide important diagnostic information if performed and interpreted skilfully and has a role in guiding therapy. We discuss how it is performed, how to interpret the results, and when it can make a difference to the investigation and treatment of patients with syncope.
This video was partially funded by an unrestricted educational grant from Novartis.
Key Learning Objectives
With this webinar we aim to:
- Increase knowledge and competence around managing the syncope patient, according to 2018 ESC guidelines on syncope.
- Understand practical implementation strategies of the guidelines.
Target Audience
This webinar aims to educate the following:
- Cardiologists and electrophysiologists
- Internal medical professionals/primary care
More from this programme
Part 1
New Horizons in AF
New Horizons in AF was a scientific meeting which highlighted current approaches to the diagnosis and treatment of atrial fibrillation.
| 1 session | |
| New Horizons in AF | Watch now |
Part 2
Welcome & Current State of the Art
In this video, Prof John Morgan welcomes the faculty alongside co-Chair, Prof Serge Boveda, to introduce Prof Isabel Deisenhofer.
| 1 session | |
| Welcome & Current State of the Art | Watch now |
Part 3
Personalised AF Therapies in the Hands of All EPs
In this video, Prof John Morgan welcomes the faculty alongside co-Chair, Prof Serge Boveda, to introduce Prof Isabel Deisenhofer.
| 1 session | |
| The Big AF Debate | Watch now |
Faculty Biographies